Ioversol Injection

• • Optiray 300 solution for injection, Guerbet, 100 mL bottle, 12 count, NDC 00019-1332-11
  • Optiray 300 solution for injection, Guerbet, 100 mL prefilled syringe, 20 count, NDC 00019-1332-90
  • Optiray 300 solution for injection, Guerbet, 100 mL RFID technology prefilled syringe, NDC 00019-1332-00
  • Optiray 300 solution for injection, Guerbet, 200 mL bottle, 12 count, NDC 00019-1332-21
  • Optiray 300 solution for injection, Guerbet, 50 mL Hand Held prefilled syringe, 20 count, NDC 00019-1332-78
  • Optiray 300 solution for injection, Guerbet, 50 mL vial, 25 count, NDC 00019-1332-06
  • Optiray 300 solution for injection, Guerbet, 500 mL pharmacy bulk pack, multi-dose bottle, 6 count, NDC 00019-1332-61 - discontinued
  • Optiray 320 solution for injection, Guerbet, 100 mL bottle, 12 count, NDC 00019-1323-11
  • Optiray 320 solution for injection, Guerbet, 100 mL prefilled syringe, 20 count, NDC 00019-1323-90
  • Optiray 320 solution for injection, Guerbet, 100 mL RFID technology prefilled syringe, NDC 00019-1323-00
  • Optiray 320 solution for injection, Guerbet, 125 mL prefilled syringe, 20 count, NDC 00019-1323-87
  • Optiray 320 solution for injection, Guerbet, 125 mL RFID technology prefilled syringe, NDC 00019-1323-27
  • Optiray 320 solution for injection, Guerbet, 150 mL bottle, 12 count, NDC 00019-1323-16
  • Optiray 320 solution for injection, Guerbet, 20 mL vial, 25 count, NDC 00019-1323-02
  • Optiray 320 solution for injection, Guerbet, 200 mL bottle, 12 count, NDC 00019-1323-21
  • Optiray 320 solution for injection, Guerbet, 30 mL vial, 25 count, NDC 00019-1323-04 - discontinued
  • Optiray 320 solution for injection, Guerbet, 50 mL Hand Held prefilled syringe, 20 count, NDC 00019-1323-78
  • Optiray 320 solution for injection, Guerbet, 50 mL prefilled syringe, 20 count, NDC 00019-1323-52
  • Optiray 320 solution for injection, Guerbet, 50 mL vial, 25 count, NDC 00019-1323-06
  • Optiray 320 solution for injection, Guerbet, 500 mL pharmacy bulk pack, multi-dose bottle, 6 count, NDC 00019-1323-61 - discontinued
  • Optiray 320 solution for injection, Guerbet, 75 mL prefilled syringe, 20 count, NDC 00019-1323-95
  • Optiray 320 solution for injection, Guerbet, 75 mL RFID technology prefilled syringe, NDC 00019-1323-85
  • Optiray 350 solution for injection, Guerbet, 100 mL bottle, 12 count, NDC 00019-1333-11
  • Optiray 350 solution for injection, Guerbet, 100 mL prefilled syringe, 20 count, NDC 00019-1333-90
  • Optiray 350 solution for injection, Guerbet, 100 mL RFID technology prefilled syringe, NDC 00019-1333-00
  • Optiray 350 solution for injection, Guerbet, 125 mL prefilled syringe, 20 count, NDC 00019-1333-87
  • Optiray 350 solution for injection, Guerbet, 125 mL RFID technology prefilled syringe, NDC 00019-1333-27
  • Optiray 350 solution for injection, Guerbet, 150 mL bottle, 12 count, NDC 00019-1333-16
  • Optiray 350 solution for injection, Guerbet, 200 mL bottle, 12 count, NDC 00019-1333-21
  • Optiray 350 solution for injection, Guerbet, 50 mL Hand Held prefilled syringe, 20 count, NDC 00019-1333-78
  • Optiray 350 solution for injection, Guerbet, 50 mL prefilled syringe, 20 count, NDC 00019-1333-52 - discontinued
  • Optiray 350 solution for injection, Guerbet, 50 mL RFID technology prefilled syringe, NDC 00019-1333-55 - discontinued
  • Optiray 350 solution for injection, Guerbet, 50 mL vial, 25 count, NDC 00019-1333-06
  • Optiray 350 solution for injection, Guerbet, 500 mL pharmacy bulk pack, multi-dose bottle, 6 count, NDC 00019-1333-61 - discontinued
  • Optiray 350 solution for injection, Guerbet, 75 mL prefilled syringe, 20 count, NDC 00019-1333-95

• • Iohexol (Omnipaque - GE Healthcare) injection is currently in shortage due to the shutdown of a production facility in Shanghai, China during a COVID-19 lockdown. The facility is open again and production is operating at full capacity. As a result of the iohexol shortage, other contrast agents may be affected as organizations seek suitable alternatives.
  • Guerbet states Optiray is on back order due to a shortage of raw material.

• • There are no presentations available.

Estimated Resupply Dates

• • Guerbet has Optiray 300 100 mL bottles on back order and the company estimates release dates of late-January 2023. All other Optiray 300 presentations are on back order and the company cannot estimate release dates.
  • Guerbet has Optiray 320 50 mL vials on back order and the company estimates a release date of late-January 2023. All other Optiray 320 presentations are on back order and the company cannot estimate release dates.
  • Guerbet has Optiray 350 125 mL power injector syringes on back order and the company estimates a release date of late-January 2023. Optiray 50 mL glass bottles are on back order and the company estimates a release date of late-January 2023. Optiray 350 150 mL and 200 mL bottles are on back order and the company estimates a release date of mid-January 2023. All other Optiray 350 mL presentations are on back order and the company cannot estimate release dates.

Alternative Agents & Management

• • More information can be found at Considerations for Imaging Contrast Shortage Management and Conservation
  • The American College of Radiology (ACR) has issued a statement addressing the shortage of iodinated contrast media. https://www.acr.org/Advocacy-and-Economics/ACR-Position-Statements/Contrast-Media-Shortage